| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |